When should at-risk patients with thalassaemia be boosted with hepatitis B vaccine?

Lancet. 1987 Jun 6;1(8545):1321. doi: 10.1016/s0140-6736(87)90576-9.
No abstract available

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Hepatitis B Vaccines
  • Humans
  • Immunization, Secondary*
  • Risk
  • Thalassemia*
  • Viral Hepatitis Vaccines / administration & dosage*

Substances

  • Hepatitis B Vaccines
  • Viral Hepatitis Vaccines